Lopez D, McLean M P
Department of Obstetrics and Gynecology, University of South Florida College of Medicine, Tampa 33606, USA.
Endocrinology. 1999 Dec;140(12):5669-81. doi: 10.1210/endo.140.12.7220.
The high density lipoprotein (HDL) receptor, or scavenger receptor class B type I (SR-BI), is critical for cholesterol transport and a potential target for hypercholesterolemic drugs. Thus, elucidation of the mechanism underlying regulation of the HDL receptor SR-BI gene is essential. It has been previously shown that there is a correlation between depletion in ovarian cholesteryl ester content and increased HDL receptor SR-BI expression in response to hormonal stimulation. We wanted to determine whether the levels of mature sterol response element-binding protein-1a (SREBP-1a), a key protein in the transcriptional regulation of several genes by sterols, are affected under these conditions. Thus, Western blot analysis was carried out. Consistent with the possibility that SREBP-1a may be involved in the regulation of the HDL receptor SR-BI gene, we found that mature SREBP-1a levels increased up to 11-fold in the ovary after treatment with 50 U hCG. This increase in mature SREBP-1a protein levels correlated with a 30% decrease in ovarian cholesterol levels. These changes in both SREBP-1a and cholesterol levels preceded a 2-fold induction of HDL receptor SR-BI protein levels. To determine whether SREBP-1a could directly regulate the expression of the rat HDL receptor SR-BI gene, approximately 2.2 kb of the receptor SR-BI promoter were cloned and sequenced, and deletion analysis and mobility shift assays were performed. The results of these studies demonstrate that the rat HDL receptor SR-BI promoter contains two sterol response elements (pSRE and dSRE) through which SREBP-1a can bind and activate transcription of this gene. These motifs are similar to known SRE motifs reported for sterol-sensitive genes, and the pSRE is located between two Sp1 sites, similar to the SRE-1 motif in the low density lipoprotein receptor. The cysteine protease inhibitor N-acetyl-leucyl-leucyl-norleucinal, which inhibits SREBP degradation, enhanced the effect of SREBP-1a on the regulation of the rat HDL receptor SR-BI gene. It has previously been shown that tropic hormones such as hCG can also influence gene expression by increasing cAMP levels. Consistent with this fact, we have recently shown that steroidogenic factor-1 (SF-1) mediates cAMP activation of the HDL receptor SR-BI gene. Thus, we decided to examine whether SREBP-1a could cooperate with SF-1 to enhance transcription this gene. The results confirm that indeed both SF-1 and SREBP-1a synergize to induce HDL receptor SR-BI gene expression.
高密度脂蛋白(HDL)受体,即B类I型清道夫受体(SR - BI),对胆固醇转运至关重要,是高胆固醇血症药物的潜在靶点。因此,阐明HDL受体SR - BI基因调控的潜在机制至关重要。此前已有研究表明,卵巢胆固醇酯含量的减少与激素刺激后HDL受体SR - BI表达增加之间存在关联。我们想确定在这些条件下,成熟的固醇调节元件结合蛋白-1a(SREBP - 1a)水平是否会受到影响,SREBP - 1a是一种通过固醇对多个基因进行转录调控的关键蛋白。因此,我们进行了蛋白质免疫印迹分析。与SREBP - 1a可能参与HDL受体SR - BI基因调控的可能性一致,我们发现用50 U人绒毛膜促性腺激素(hCG)处理后,卵巢中成熟SREBP - 1a水平增加了11倍。成熟SREBP - 1a蛋白水平的这种增加与卵巢胆固醇水平降低30%相关。SREBP - 1a和胆固醇水平的这些变化先于HDL受体SR - BI蛋白水平2倍的诱导。为了确定SREBP - 1a是否能直接调控大鼠HDL受体SR - BI基因的表达,我们克隆并测序了约2.2 kb的受体SR - BI启动子,并进行了缺失分析和凝胶迁移实验。这些研究结果表明,大鼠HDL受体SR - BI启动子包含两个固醇反应元件(pSRE和dSRE),SREBP - 1a可通过它们结合并激活该基因的转录。这些基序与报道中的固醇敏感基因的已知SRE基序相似,且pSRE位于两个Sp1位点之间,类似于低密度脂蛋白受体中的SRE - 1基序。抑制SREBP降解的半胱氨酸蛋白酶抑制剂N - 乙酰 - 亮氨酰 - 亮氨酰 - 正亮氨酸增强了SREBP - 1a对大鼠HDL受体SR - BI基因调控的作用。此前已有研究表明,诸如hCG等促性腺激素也可通过提高cAMP水平来影响基因表达。与此事实一致,我们最近发现类固醇生成因子-1(SF - 1)介导了HDL受体SR - BI基因的cAMP激活。因此,我们决定研究SREBP - 1a是否能与SF - 1协同作用以增强该基因的转录。结果证实,SF - 1和SREBP - 1a确实协同诱导HDL受体SR - BI基因表达。